Sigyn Therapeutics, Inc. (SIGY)

CIK 1642159 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Sigyn Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Jul 16, 202615-12G0001493152-26-033421
Mar 31, 2026NT 10-K0001493152-26-014344
Feb 20, 20268-K0001493152-26-007574
Jan 14, 2026SCHEDULE 13G/A0001213900-26-004186
Nov 14, 202510-Q0001493152-25-023387
Sep 5, 202510-Q0001641172-25-026704
Aug 15, 2025NT 10-Q0001641172-25-024221
Aug 15, 20258-K0001641172-25-024303
May 20, 202510-Q0001641172-25-011815
May 15, 2025NT 10-Q0001641172-25-010720
Apr 15, 202510-K0001641172-25-004740
Mar 31, 2025NT 10-K0001641172-25-001760
Mar 7, 20258-K0001493152-25-009462
Feb 14, 2025SCHEDULE 13G/A0001213900-25-014469
Jan 16, 20258-K0001493152-25-002575
Jan 6, 20258-K0001493152-25-001074
Nov 19, 202410-Q0001493152-24-046847
Nov 15, 2024NT 10-Q0001493152-24-046127
Oct 16, 20248-K/A0001493152-24-041285
Oct 16, 20248-K0001493152-24-041287
Oct 7, 20248-K0001493152-24-039594
Aug 30, 2024RW0001493152-24-034654
Aug 19, 202410-Q0001493152-24-033048
Aug 14, 2024NT 10-Q0001493152-24-032398
Jun 6, 20248-K0001493152-24-022945